NOTHING INNOVATIVE ABOUT CERTIS BIOLOGICALS

I realized Certis Biologicals is not an innovative company. All they do is acquired products or strains from other companies. I understand this might be the case years ago when the Research and Development department consists only four people. Now, they doubled the size of the department and they are still using the same strategy. Why did you hired all these people for?

For example, Howler EVO and Theia. These two products were acquired from Agbiome. Convergence is literally the same product as Double Nickel LC, but repackaged for row crops. If you look at their labels, both Convergence and Double Nickel LC have the same formulation and EPA registration number. They also have to pay royalties for Bacillus amyloliquefaciens (active ingredient for Double Nickel and Covergence) and B. mycoides Jacobsen (active ingredient for Lifeguard). 

Since the original people who worked there for decades retire and people who worked under these retirees also quit, the company haven't acquired or screened for their own microbe or active ingredient for decades. They are taking the easy way out. The current Director of Research and Innovation is really clueless. They aren't innovative when they are just acquiring products and renaming an existing product as a new product!